Compugen Current Ratio 2006-2021 | CGEN

Compugen current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Compugen Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.11B $0.01B 9.60
2021-03-31 $0.12B $0.01B 10.65
2020-12-31 $0.13B $0.01B 12.27
2020-09-30 $0.13B $0.01B 16.93
2020-06-30 $0.14B $0.01B 17.01
2020-03-31 $0.12B $0.01B 14.04
2019-12-31 $0.05B $0.01B 6.60
2019-09-30 $0.05B $0.01B 7.19
2019-06-30 $0.04B $0.01B 5.38
2019-03-31 $0.04B $0.01B 5.11
2018-12-31 $0.05B $0.01B 4.66
2018-09-30 $0.04B $0.01B 4.61
2018-06-30 $0.04B $0.01B 5.92
2018-03-31 $0.03B $0.01B 5.81
2017-12-31 $0.03B $0.01B 5.03
2017-09-30 $0.04B $0.01B 6.73
2017-06-30 $0.05B $0.01B 9.38
2017-03-31 $0.06B $0.01B 10.63
2016-12-31 $0.06B $0.01B 13.22
2016-09-30 $0.07B $0.01B 14.90
2016-06-30 $0.08B $0.01B 16.73
2016-03-31 $0.08B $0.01B 14.32
2015-12-31 $0.09B $0.01B 13.28
2015-09-30 $0.08B $0.01B 15.00
2015-06-30 $0.10B $0.01B 18.69
2015-03-31 $0.07B $0.01B 13.11
2014-12-31 $0.08B $0.01B 11.40
2014-09-30 $0.11B $0.01B 21.59
2014-06-30 $0.12B $0.01B 17.20
2014-03-31 $0.12B $0.01B 14.56
2013-12-31 $0.05B $0.01B 6.88
2013-09-30 $0.05B $0.01B 5.64
2013-06-30 $0.03B $0.00B 16.26
2013-03-31 $0.03B $0.00B 17.12
2012-12-31 $0.03B $0.00B 18.53
2012-09-30 $0.02B $0.00B 11.86
2012-06-30 $0.02B $0.00B 14.70
2012-03-31 $0.03B $0.00B 12.32
2011-12-31 $0.02B $0.00B 13.53
2011-09-30 $0.02B $0.00B 16.27
2011-06-30 $0.03B $0.00B 20.06
2011-03-31 $0.03B $0.00B 16.65
2010-12-31 $0.03B $0.00B 11.50
2010-09-30 $0.02B $0.00B 18.41
2010-06-30 $0.02B $0.00B 20.22
2010-03-31 $0.02B $0.00B 15.04
2009-12-31 $0.02B $0.00B 16.54
2009-09-30 $0.01B $0.00B 7.83
2009-06-30 $0.01B $0.00B 8.62
2009-03-31 $0.01B $0.00B 6.81
2008-12-31 $0.01B $0.00B 4.05
2008-09-30 $0.01B $0.00B 4.30
2008-06-30 $0.01B $0.00B 4.81
2008-03-31 $0.02B $0.00B 6.66
2007-12-31 $0.02B $0.00B 5.62
2007-09-30 $0.02B $0.00B 5.46
2007-06-30 $0.02B $0.00B 10.00
2007-03-31 $0.03B $0.00B 11.45
2006-12-31 $0.03B $0.00B 8.90
2006-09-30 $0.02B $0.00B 11.80
2006-06-30 $0.03B $0.00B 12.92
2006-03-31 $0.03B $0.00B 10.83
2005-12-31 $0.03B $0.00B 8.85
2005-09-30 $0.03B $0.00B 13.72
2005-06-30 $0.02B $0.00B 9.09
2005-03-31 $0.02B $0.00B 10.19
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.422B $0.002B
Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86